Monday, February 15, 2016

Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (B): Business Model Innovation in Vaccine Delivery

PARKER Philip M., PIERFITTE Marion
©2016 INSEAD Case Study
Also available: Teaching Note 
Get the case from INSEAD Case Publishing

This case explores the difficulties involved in commercialising vaccines in low-income settings. The focus is the dengue vaccine, launched at the end of 2015, which was first commercialised in emerging markets. It considers issues of affordability and distribution, higlighting the need for business model innovation in all industries.